Patient Portal

Mark A. Schroeder, MD

Assistant Professor, Medicine
Medical Oncology, BMT and Leukemia

Specialty Areas

Bone Marrow Transplant
Hematology
Oncology
Hematologic Malignancies

Board Certifications

American Board of Internal Medicine, Medical Oncology
American Board of Internal Medicine
American Board of Internal Medicine, Hematology

Hospital Affiliations

Barnes-Jewish Hospital

Referral Information

Not Accepting New Patients

Areas of Clinical Interest

Oncology, cancer, bone marrow transplant, leukemia, MDS, graft-versus-host disease, transplant biology

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Barnes-Jewish Hospital

1 Barnes-Jewish Hospital Plaza
St. Louis, MO 63110

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Siteman Cancer Center
Barnes-Jewish St. Peters Hospital

150 Entrance Way
St. Peters, MO 63376

Education

Education

Bachelor of Science: University of Toledo, Toledo, OH 1999
Medical Degree: University of Cincinnati, College of Medicine, Cincinnati, Ohio 2003
Residency, Internal Medicine: Barnes Jewish Hospital, St. Louis, MO 2006
Fellowship, Hematology and Oncology : Washington University School of Medicine, St. Louis, MO 2009
MS - Clinical Investigation: Washington University School of Medicine, St. Louis, MO 2012

Publication & Research

Publication & Research

Modeling Chronic Graft Versus Host Disease in Mice Using Allogeneic Bone Marrow and Splenocyte Transfer.
Schroeder MA, Ashami K, Staser K
Curr Protoc Pharmacol. 2018 Sep 11; e47. doi: 10.1002/cpph.47.

PMID:
    30204297
    [PubMed - as supplied by publisher]
Related citations


Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results.
Cortes JE, Douglas Smith B, Wang ES, Merchant A, Oehler VG, Arellano M, DeAngelo DJ, Pollyea DA, Sekeres MA, Robak T, Ma WW, Zeremski M, Naveed Shaik M, Douglas Laird A, O'Connell A, Chan G, Schroeder MA
Am J Hematol. 2018 Aug 3; doi: 10.1002/ajh.25238.

PMID:
    30074259
    [PubMed - as supplied by publisher]
Related citations


Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance.
Perry JSA, Russler-Germain EV, Zhou YW, Purtha W, Cooper ML, Choi J, Schroeder MA, Salazar V, Egawa T, Lee BC, Abumrad NA, Kim BS, Anderson MS, DiPersio JF, Hsieh CS
Immunity. 2018 Jun 19; 48(6)1271. doi: 10.1016/j.immuni.2018.05.011.

PMID:
    29924978
    [PubMed - in process]
Related citations


Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
Kurokawa C, Iankov ID, Anderson SK, Aderca I, Leontovich AA, Maurer MJ, Oberg AL, Schroeder MA, Giannini C, Greiner SM, Becker MA, Thompson EA, Haluska P, Jentoft ME, Parney IF, Weroha SJ, Jen J, Sarkaria JN, Galanis E
J Natl Cancer Inst. 2018 May 16; doi: 10.1093/jnci/djy033.

PMID:
    29788332
    [PubMed - as supplied by publisher]
Related citations


CD36 Mediates Cell-Surface Antigens to Promote Thymic Development of the Regulatory T Cell Receptor Repertoire and Allo-tolerance.
Perry JSA, Russler-Germain EV, Zhou YW, Purtha W, Cooper ML, Choi J, Schroeder MA, Salazar V, Egawa T, Lee BC, Abumrad NA, Kim BS, Anderson MS, DiPersio JF, Hsieh CS
Immunity. 2018 May 15; 48(5)923-936.e4. doi: 10.1016/j.immuni.2018.04.007.

PMID:
    29752065
    [PubMed - in process]
Related citations


A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure.
Zeidan AM, Knaus HA, Robinson TM, Towlerton AMH, Warren EH, Zeidner JF, Blackford AL, Duffield AS, Rizzieri D, Frattini MG, Levy YM, Schroeder MA, Ferguson A, Sheldon KE, DeZern AE, Gojo I, Gore SD, Streicher H, Luznik L, Smith BD
Clin Cancer Res. 2018 Aug 1; 24(15)3519-3527. doi: 10.1158/1078-0432.CCR-17-3763.

PMID:
    29716921
    [PubMed - in process]
Related citations


Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease.
Choi J, Cooper ML, Staser K, Ashami K, Vij KR, Wang B, Marsala L, Niswonger J, Ritchey J, Alahmari B, Achilefu S, Tsunoda I, Schroeder MA, DiPersio JF
Leukemia. 2018 Apr 2; doi: 10.1038/s41375-018-0123-z.

PMID:
    29691471
    [PubMed - as supplied by publisher]
Related citations


Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.
Zhou D, Alver BM, Li S, Hlady RA, Thompson JJ, Schroeder MA, Lee JH, Qiu J, Schwartz PH, Sarkaria JN, Robertson KD
Genome Biol. 2018 Mar 27; 19(1)43. doi: 10.1186/s13059-018-1420-6.

PMID:
    29587824
    [PubMed - indexed for MEDLINE]
Related citations


Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS.
Savona MR, Pollyea DA, Stock W, Oehler VG, Schroeder MA, Lancet J, McCloskey J, Kantarjian HM, Ma WW, Shaik MN, Laird AD, Zeremski M, O'Connell A, Chan G, Cortes JE
Clin Cancer Res. 2018 May 15; 24(10)2294-2303. doi: 10.1158/1078-0432.CCR-17-2824.

PMID:
    29463550
    [PubMed - in process]
Related citations


The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.
Schroeder MA, Choi J, Staser K, DiPersio JF
Biol Blood Marrow Transplant. 2018 Jun; 24(6)1125-1134. doi: 10.1016/j.bbmt.2017.12.797.

PMID:
    29289756
    [PubMed - in process]
Related citations


Hyperpolarized [1,4-<sup>13</sup>C<sub>2</sub>]Fumarate Enables Magnetic Resonance-Based Imaging of Myocardial Necrosis.
Miller JJ, Lau AZ, Nielsen PM, McMullen-Klein G, Lewis AJ, Jespersen NR, Ball V, Gallagher FA, Carr CA, Laustsen C, Bøtker HE, Tyler DJ, Schroeder MA
JACC Cardiovasc Imaging. 2017 Dec 8; pii: S1936-878X(17)30988-9. doi: 10.1016/j.jcmg.2017.09.020.

PMID:
    29248653
    [PubMed - as supplied by publisher]
Related citations


Probing the cardiac malate-aspartate shuttle non-invasively using hyperpolarized [1,2-<sup>13</sup> C<sub>2</sub> ]pyruvate.
Chen AP, Lau AZ, Gu YP, Schroeder MA, Barry J, Cunningham CH
NMR Biomed. 2018 Jan; 31(1)doi: 10.1002/nbm.3845.

PMID:
    29106770
    [PubMed - indexed for MEDLINE]
Related citations


Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.
Ali AM, Weisel D, Gao F, Uy GL, Cashen AF, Jacoby MA, Wartman LD, Ghobadi A, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Schroeder MA, Westervelt P, DiPersio JF, Welch JS
Cancer Med. 2017 Dec; 6(12)2814-2821. doi: 10.1002/cam4.1231.

PMID:
    29058375
    [PubMed - indexed for MEDLINE]
Related citations


Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy.
Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Schroeder MA, Gao F, Romee R
Bone Marrow Transplant. 2017 Dec; 52(12)1623-1628. doi: 10.1038/bmt.2017.193.

PMID:
    29035393
    [PubMed - indexed for MEDLINE]
Related citations


Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma.
Kizilbash SH, Gupta SK, Chang K, Kawashima R, Parrish KE, Carlson BL, Bakken KK, Mladek AC, Schroeder MA, Decker PA, Kitange GJ, Shen Y, Feng Y, Protter AA, Elmquist WF, Sarkaria JN
Mol Cancer Ther. 2017 Dec; 16(12)2735-2746. doi: 10.1158/1535-7163.MCT-17-0365.

PMID:
    28947502
    [PubMed - indexed for MEDLINE]
Related citations


Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.
Bhamidipati PK, Fiala MA, Grossman BJ, DiPersio JF, Stockerl-Goldstein K, Gao F, Uy GL, Westervelt P, Schroeder MA, Cashen AF, Abboud CN, Vij R
Biol Blood Marrow Transplant. 2017 Dec; 23(12)2065-2069. doi: 10.1016/j.bbmt.2017.07.023.

PMID:
    28797783
    [PubMed - indexed for MEDLINE]
Related citations


Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of Glioblastoma.
Pedron S, Hanselman JS, Schroeder MA, Sarkaria JN, Harley BAC
Adv Healthc Mater. 2017 Nov; 6(21)doi: 10.1002/adhm.201700529.

PMID:
    28766870
    [PubMed - indexed for MEDLINE]
Related citations


Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Slade M, DiPersio JF, Westervelt P, Vij R, Schroeder MA, Romee R
Biol Blood Marrow Transplant. 2017 Oct; 23(10)1736-1743. doi: 10.1016/j.bbmt.2017.06.019.

PMID:
    28688919
    [PubMed - indexed for MEDLINE]
Related citations


Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In Vivo.
Cooper ML, Choi J, Karpova D, Vij K, Ritchey J, Schroeder MA, DiPersio JF
J Immunol. 2017 May 1; 198(9)3746-3754. doi: 10.4049/jimmunol.1502399.

PMID:
    28330901
    [PubMed - indexed for MEDLINE]
Related citations


Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.
Schroeder MA, Rettig MP, Lopez S, Christ S, Fiala M, Eades W, Mir FA, Shao J, McFarland K, Trinkaus K, Shannon W, Deych E, Yu J, Vij R, Stockerl-Goldstein K, Cashen AF, Uy GL, Abboud CN, Westervelt P, DiPersio JF
Blood. 2017 May 11; 129(19)2680-2692. doi: 10.1182/blood-2016-09-739722.

PMID:
    28292947
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2017:

Company Name: Quintiles

Royalties:

Equity: No

Consulting/Advisory Board: $10,000 - $19,999

Speaker Fees:

Reporting Date: May 01, 2018

Areas of Research Interest

Dr. Schroeder has a translational research focus in transplant biology and the development of novel therapeutics and treatment approaches for myelodysplastic syndrome and leukemia. His research in transplant biology includes improving stem cell mobilization; and, understanding and improvingtreatment of graft-versus-host disease. His clinical research interest includes hematologic malignancies, such as MDS, AML, and CLL; and, their treatment by hematopoietic stem cell transplantation and the development of new treatment approaches.